See every side of every news story
Published loading...Updated

PIPEs, biopharma’s favorite financing vehicle, freeze amid market struggles

Summary by Endpoints News
PIPEs have fallen out of favor. The private investment in public equity, or PIPE, had one of the best years on record in 2024. The financing instrument has a clubby feel in which drug developers ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Express Healthcare broke the news in on Thursday, April 3, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.